ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Clonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4,1,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
7,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
8,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
9,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
9,4,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
10,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
11,1,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
12,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
15,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
15,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
17,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
17,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
18,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
22,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
23,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
24,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
25,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
27,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
29,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
31,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
32,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
33,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,2,Headache,Headaches NEC,Headaches,Nerv,N
33,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
33,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
33,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
35,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
38,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
39,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
39,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
40,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
41,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
42,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
43,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
44,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
44,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
44,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
45,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
46,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
46,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
47,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
48,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
48,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
49,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
49,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
51,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
52,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
52,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
53,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
53,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
53,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
54,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
54,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
54,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
58,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
59,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
60,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
61,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
62,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
62,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
63,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
64,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
67,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
68,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
68,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
70,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
70,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
71,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
72,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
72,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
73,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
74,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
75,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
76,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
78,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
79,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
80,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
83,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
84,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
85,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
87,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
88,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
90,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
90,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
90,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
92,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
92,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
95,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
97,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
97,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
97,3,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
97,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
97,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
98,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
99,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
99,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
99,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
99,4,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
99,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
99,6,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
99,7,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
99,8,Leukocyturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
99,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
99,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,11,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
100,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
100,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,4,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
100,5,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
101,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
102,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
102,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
103,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
105,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
106,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
106,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
107,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
108,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
108,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
109,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
109,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
109,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
110,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
111,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
114,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
114,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
114,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
114,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
114,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
114,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,8,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
114,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
114,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
114,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
115,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
115,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
116,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
116,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
117,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
119,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
123,1,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
124,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
125,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
126,1,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
126,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
127,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
128,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
129,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
130,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
130,2,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
130,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
130,4,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
130,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
131,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
132,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
133,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
133,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
133,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
133,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
133,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
133,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
133,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
133,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
133,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
133,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
135,1,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
136,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
137,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
138,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
138,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
139,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
140,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
141,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
143,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
143,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
143,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
143,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
144,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
145,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
146,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
146,2,Vital functions abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
147,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
147,2,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
147,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
148,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
148,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
148,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
148,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
148,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
149,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
150,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
151,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
151,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
151,4,Headache,Headaches NEC,Headaches,Nerv,N
151,5,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
151,6,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
151,7,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
151,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
151,10,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
151,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
151,13,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
152,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
153,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
153,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
153,3,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
153,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
153,5,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
153,6,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
153,7,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
154,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
154,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
155,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
156,1,Headache,Headaches NEC,Headaches,Nerv,N
156,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
156,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
157,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
157,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
157,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
157,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
158,1,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
159,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
160,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
161,1,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
161,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
163,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
163,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
163,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
164,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
164,3,Thrombocytopenia neonatal,Thrombocytopenias,Platelet disorders,Blood,N
165,1,Enterococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
165,2,Haematological malignancy,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
165,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
165,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
166,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
168,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
168,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
169,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
169,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
169,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
169,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
169,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
169,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
170,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
170,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
170,5,Headache,Headaches NEC,Headaches,Nerv,N
170,6,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
170,7,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
170,8,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
170,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
170,11,Spontaneous hyphaema,Anterior chamber bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
170,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
171,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
172,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
173,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
173,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
175,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
175,2,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
175,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
175,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
176,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
177,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
177,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
177,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
178,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
179,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
179,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
179,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
180,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
180,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
180,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
181,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
182,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
182,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
183,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
183,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
184,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
184,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
185,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
185,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
185,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
185,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
186,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
186,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
186,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
186,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
187,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
188,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
188,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
189,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
189,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
190,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
191,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
191,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
192,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
192,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
193,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
193,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
194,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
197,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
198,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
199,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
200,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
200,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
200,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
200,4,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
201,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
202,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
203,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
204,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
204,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
205,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
205,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
206,1,Cross sensitivity reaction,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
206,2,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
207,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
208,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
209,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
210,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
211,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
212,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
213,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
214,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
215,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
216,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
216,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
216,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
216,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
216,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
216,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
216,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
216,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
216,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
216,10,Mycobacterium fortuitum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
216,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
216,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
216,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
216,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
216,15,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
216,16,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
217,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
218,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
218,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
218,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
218,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
219,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
219,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
219,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
220,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
221,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
222,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
222,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
223,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
223,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
223,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
224,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
224,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
224,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
225,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
225,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
226,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
227,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
228,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
229,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,2,Myopathy,Myopathies,Muscle disorders,Musc,Y
229,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
230,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
230,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
230,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
230,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
230,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
230,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
231,1,Neutropenia neonatal,Neutropenias,White blood cell disorders,Blood,N
232,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
233,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
234,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
235,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
235,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
235,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
235,4,Headache,Headaches NEC,Headaches,Nerv,N
235,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
235,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
236,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
236,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
236,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
236,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
237,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
237,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
237,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
237,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
238,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
238,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
238,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
238,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
238,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
238,7,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
238,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
239,1,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
240,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
240,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
241,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
241,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
242,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
242,2,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
242,3,Congenital multiplex arthrogryposis,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
242,4,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
242,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
242,6,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
242,7,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
243,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
244,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
245,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
245,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
246,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
247,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
248,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
248,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
248,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
249,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
249,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
249,3,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
249,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
249,5,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
249,6,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
249,7,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
249,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
249,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
250,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
250,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
250,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
251,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
251,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
252,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
253,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
254,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
254,2,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
254,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
254,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
254,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
254,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
254,7,Splenic embolism,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
254,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
255,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
255,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
255,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
255,4,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
255,5,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
256,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
257,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
257,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
257,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
257,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
257,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
257,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
257,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
258,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
260,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
260,2,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
261,1,Tooth deposit,Dental surface disorders,Dental and gingival conditions,Gastr,N
261,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
262,1,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
262,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
263,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
264,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
265,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
266,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
267,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
267,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
269,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
270,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
270,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
271,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
272,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
273,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
273,2,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
274,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
275,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
276,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
276,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
276,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
276,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
276,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
276,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
277,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
277,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
278,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
279,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
280,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
281,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
282,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
282,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
282,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
282,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,5,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
282,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
282,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
282,8,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
283,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
284,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
284,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
285,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
285,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
286,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
287,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
288,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
288,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
288,3,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
288,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
289,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
290,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
290,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
290,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
290,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
291,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
291,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
291,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
291,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
291,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
291,7,Headache,Headaches NEC,Headaches,Nerv,N
291,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
291,10,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
291,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,12,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
291,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
292,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
292,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
293,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
293,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
294,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
295,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
296,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
296,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
296,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
297,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
298,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
298,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
299,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
299,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
300,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
300,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
300,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
300,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
300,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
301,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
302,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
302,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
302,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
302,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
302,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
303,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
303,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
305,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
305,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
306,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
306,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
306,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
306,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
306,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
306,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
307,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
307,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
308,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
308,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
308,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
308,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
308,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
309,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
310,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
310,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
310,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,4,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
310,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
310,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
310,7,Periprosthetic fracture,Musculoskeletal procedural complications,Procedural related injuries and complications NEC,Inj&P,N
310,8,Sinusitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
311,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
311,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
311,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
311,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
311,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
312,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
312,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
312,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
312,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
313,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
313,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
313,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
313,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
314,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
314,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
314,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
314,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
315,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
316,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
318,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
319,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
320,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
320,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
322,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
322,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
324,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
324,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
324,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
327,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
328,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
329,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
330,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
331,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
331,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
332,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
332,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
333,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
334,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
335,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
335,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
335,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
335,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
336,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
337,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
338,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
338,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
339,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
341,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
341,3,Intertrigo,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
342,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
342,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
343,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
344,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
344,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
345,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
346,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
347,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
348,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
348,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
348,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
348,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,5,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
349,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
350,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
350,2,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
351,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
351,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
352,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
352,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
352,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
352,4,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
352,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
353,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
353,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
354,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
355,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
355,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
355,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
355,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
356,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
357,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
357,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
358,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
358,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
358,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
359,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
360,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
361,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
362,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
363,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
363,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
363,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
363,4,Monocytopenia,Leukopenias NEC,White blood cell disorders,Blood,N
363,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
363,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
363,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
364,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
364,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
364,3,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
364,4,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
364,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
365,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
365,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
365,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
367,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
368,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
369,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,Y
370,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
370,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
370,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
370,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
370,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
370,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
370,8,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
370,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
371,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
372,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
373,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
374,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
375,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
376,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
377,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
377,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
378,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
378,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
379,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
381,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
381,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
381,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
381,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
381,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
382,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
383,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
384,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
385,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
385,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
386,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
387,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
387,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
388,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
388,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
388,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
389,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
390,1,Blood pressure immeasurable,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
390,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
390,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
391,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
392,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
392,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
392,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
392,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
392,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
393,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
394,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
395,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
396,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
396,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
396,3,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
396,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
396,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
396,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
397,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
397,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
398,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
399,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
400,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
400,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
400,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
400,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
400,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
401,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
402,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
403,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
404,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
404,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
405,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
406,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
407,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
408,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
409,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
410,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
412,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
412,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
412,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
412,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
413,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
413,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
413,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
414,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
414,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
415,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
415,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
416,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
417,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
417,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
418,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
418,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
418,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
419,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
421,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
422,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
422,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
422,4,Clostridium bacteraemia,Clostridia infections,Bacterial infectious disorders,Infec,N
422,5,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
422,6,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
422,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
422,8,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
422,9,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
422,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
423,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
424,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
425,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
426,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
427,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
428,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
429,1,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
429,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
430,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
430,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
430,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
430,4,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
430,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
430,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
430,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
430,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
431,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
432,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
432,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
433,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
434,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
434,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
434,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
435,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
435,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
435,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
436,1,Candida endophthalmitis,Candida infections,Fungal infectious disorders,Infec,N
437,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
437,2,Dysbiosis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
437,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
437,4,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
437,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
438,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
438,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
439,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
439,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
439,3,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
439,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
439,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
439,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
439,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,Y
439,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
439,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
439,10,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
439,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
439,12,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
440,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
440,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
441,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
442,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
443,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
444,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
444,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
444,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
445,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
445,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
445,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
446,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
447,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
447,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
447,3,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
447,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
447,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
448,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
449,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
450,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
450,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
450,3,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
450,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
450,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
450,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,Y
450,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
450,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,10,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
450,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
450,12,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
451,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
452,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
452,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
453,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
453,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
454,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
454,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
455,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
455,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
456,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
456,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
456,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
457,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
457,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
457,3,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
457,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
457,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
457,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
457,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
457,8,Neurilemmoma benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
457,9,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
458,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
458,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
458,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
458,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
458,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
458,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
459,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
459,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
459,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
459,4,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
460,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
460,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
460,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
460,4,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
460,5,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
461,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
462,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
463,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
464,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
465,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
465,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
466,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
467,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
468,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
468,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
468,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
469,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
469,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
470,1,Cheyne-Stokes respiration,Breathing abnormalities,Respiratory disorders NEC,Resp,N
470,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
470,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
471,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
472,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
472,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
472,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
472,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
472,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
472,6,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
472,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
473,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
474,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
474,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
475,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
476,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
477,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
478,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
478,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
479,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
479,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
479,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
479,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
481,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
481,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
482,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
483,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
484,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
484,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
484,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
484,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
485,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
486,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
486,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
488,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
489,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
489,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
489,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
489,4,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
490,1,Cystitis klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
490,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
491,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
491,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
491,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
492,1,Convulsive threshold lowered,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
492,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
492,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
493,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
494,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
495,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
496,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
497,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
497,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
497,3,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
497,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
497,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
497,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
498,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
498,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
498,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
498,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
498,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
498,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
499,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
499,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
499,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
499,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
499,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
499,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
499,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
500,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
501,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
501,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
501,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
501,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
501,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
501,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
501,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
501,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
501,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
501,10,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
501,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
501,12,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
501,13,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
501,14,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
501,15,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
501,16,Radiation fibrosis - lung,Radiation injuries,Injuries by physical agents,Inj&P,N
501,17,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
501,18,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
501,19,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
501,20,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
503,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
504,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
505,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
505,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
505,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
505,4,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
505,5,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
506,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
507,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
508,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
508,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
509,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
509,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
510,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
510,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
510,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
510,4,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
510,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
510,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
511,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
511,2,Convulsive threshold lowered,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
511,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
512,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
513,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
513,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
513,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
514,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
514,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
514,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
514,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
514,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
514,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
514,7,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
515,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
516,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
517,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
518,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
518,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
519,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
520,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
520,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
520,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
521,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
521,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
522,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
523,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
524,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
525,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
526,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
526,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
527,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
528,1,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
528,2,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
529,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
529,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
529,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
529,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
529,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
529,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
529,7,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
529,8,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
529,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
530,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
531,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
532,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
533,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
533,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
534,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
534,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
535,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
535,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
535,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
535,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
535,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
535,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
535,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
535,8,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
536,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
536,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
537,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
538,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
540,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
541,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
541,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
541,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
541,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
541,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
542,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
542,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
543,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
544,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
544,2,Deafness,Hearing losses,Hearing disorders,Ear,N
544,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
544,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
545,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
545,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
545,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
545,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
546,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
546,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
546,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
546,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
547,1,Deafness,Hearing losses,Hearing disorders,Ear,N
547,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
548,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
549,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
549,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
550,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
550,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
551,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
552,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
552,2,Deafness,Hearing losses,Hearing disorders,Ear,N
552,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
552,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
553,1,Deafness,Hearing losses,Hearing disorders,Ear,N
553,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
554,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
555,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
555,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
555,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
555,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
556,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
556,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
556,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
556,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
557,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
557,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
557,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
558,1,Deafness,Hearing losses,Hearing disorders,Ear,N
558,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
559,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
559,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
559,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
559,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
560,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
560,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
560,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
560,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
561,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
561,2,Deafness,Hearing losses,Hearing disorders,Ear,N
561,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
561,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
561,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
561,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
562,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
562,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
562,3,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
563,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
564,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
565,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
566,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
566,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
566,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,5,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
566,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
566,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
567,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
568,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
568,2,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
568,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
569,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
570,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
571,1,Candida endophthalmitis,Candida infections,Fungal infectious disorders,Infec,N
572,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
573,1,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
574,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
575,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
575,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
576,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
577,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
577,2,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
577,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
577,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
577,6,Headache,Headaches NEC,Headaches,Nerv,N
577,7,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
577,8,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
577,9,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
577,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
577,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
577,12,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
577,14,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
578,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
579,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
580,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
581,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
582,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
583,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
585,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
585,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
586,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
587,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
587,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
587,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
587,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
587,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
588,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
588,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
588,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
588,5,Headache,Headaches NEC,Headaches,Nerv,N
588,6,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
588,7,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
588,8,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
588,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
588,10,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
588,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
589,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
590,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
590,2,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
590,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
590,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
590,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
590,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
591,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
591,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
591,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
591,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
591,6,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
592,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
593,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
593,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
593,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
593,4,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
593,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
593,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
594,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
595,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
595,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
596,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
597,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
597,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
598,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
599,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
600,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
601,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
601,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
601,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
601,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
601,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
602,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
603,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
604,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
605,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
605,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
606,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
606,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
606,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
606,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
606,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
606,6,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
607,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
607,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
607,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
608,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
609,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
609,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
610,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
611,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
611,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
612,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
613,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
614,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
615,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
615,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
615,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
615,5,Postictal state,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
616,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
616,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
616,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
616,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
616,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
616,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
616,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
616,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
616,9,Raoultella ornithinolytica infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
616,10,Serratia sepsis,Serratia infections,Bacterial infectious disorders,Infec,N
616,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
617,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
617,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
617,3,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
617,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
617,5,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
618,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
618,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
619,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
620,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
620,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
621,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
622,1,Aspergillus test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
622,2,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
622,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
622,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
622,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
622,7,Procalcitonin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
622,8,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
623,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
624,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
625,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
626,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
627,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
627,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
627,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
628,1,CNS ventriculitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
628,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
628,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
628,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
628,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
628,6,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
628,7,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
628,8,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
628,9,Migraine,Migraine headaches,Headaches,Nerv,N
628,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
628,11,Septic cerebral embolism,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
629,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,3,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
629,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
630,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
630,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
630,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
631,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
632,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
635,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
635,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
635,3,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
636,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
636,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
637,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
637,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
638,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
638,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
638,3,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
639,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
639,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
639,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
640,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
640,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
640,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,Y
640,4,Pneumonia pseudomonal,Pseudomonal infections,Bacterial infectious disorders,Infec,N
641,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
642,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
642,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
642,3,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
643,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
643,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
643,3,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
644,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
645,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
646,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
646,2,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
647,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
647,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
648,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
649,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
649,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
649,3,Urticaria pigmentosa,Urticarias,Angioedema and urticaria,Skin,N
650,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
650,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
651,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
652,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
653,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
653,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
654,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
654,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
655,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
655,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
655,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
656,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
656,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
656,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
656,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
657,1,Acetabulum fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
657,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
657,3,Ischaemic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
657,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
657,5,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
657,6,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
657,7,Multiple injuries,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
657,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
657,9,Traumatic liver injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
658,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
659,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
659,2,Device issue,Device issues NEC,Device issues,Prod,N
659,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
659,4,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
659,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
659,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
659,7,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
660,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
660,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
660,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
660,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
660,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
661,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
662,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
663,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
664,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
665,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
665,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
666,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
666,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
667,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
668,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
669,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
670,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
671,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
672,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
673,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
674,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
674,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
675,1,Headache,Headaches NEC,Headaches,Nerv,N
675,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
675,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
675,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
675,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
675,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
676,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
677,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
678,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
679,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
679,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
679,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
680,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
681,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
682,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
683,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
683,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
684,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
685,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
685,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
686,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
687,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
688,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
689,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
690,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
690,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
690,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
690,4,Headache,Headaches NEC,Headaches,Nerv,N
690,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
690,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
690,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
691,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
692,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
692,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
693,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
694,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
695,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
696,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
696,2,Peripheral artery aneurysm,Peripheral aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
697,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
698,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
699,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
700,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
701,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
702,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
702,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
702,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
703,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
703,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
704,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
705,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
707,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
708,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
709,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
709,2,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
709,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
709,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
709,5,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
709,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
710,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
711,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
711,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
711,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
711,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
711,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
711,6,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
711,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
712,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
713,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
714,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
715,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
716,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
717,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
718,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
719,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
719,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
719,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
719,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
719,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
719,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
719,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
720,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
721,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
722,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
723,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
724,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
725,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
